Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, UT Health Science Center Collaborating on Diabetes Dx

NEW YORK (GenomeWeb News) – Metabolon said today that it is collaborating with researchers at the University of Texas Health Science Center at San Antonio on the development of Metabolon’s pre-diabetes diagnostic products.
 
Research Triangle Park, NC-based Metabolon will analyze samples from studies being conducted by Ralph DeFronzo and his colleagues at UTHSC in an effort to discover and validate biochemical biomarkers reflective of insulin resistance and beta cell dysfunction. The markers will be used by Metabolon to develop diagnostic tests for insulin resistance and how this relates to the risk of developing metabolic diseases, such as diabetes.
 
Metabolon hopes to develop a test that can help physicians “identify asymptomatic, pre-diabetic patients years before they become diabetic,” John Ryals, CEO of Metablon, said in a statement.
 
Further terms of the alliance were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.